TD Asset Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-59,856
| Closed | -$292K | – | 1431 |
|
|
2024
Q2 | $292K | Hold |
59,856
| – | – | ﹤0.01% | 1316 |
|
|
2024
Q1 | $795K | Buy |
59,856
+12,800
| +27% | +$170K | ﹤0.01% | 1218 |
|
|
2023
Q4 | $656K | Buy |
47,056
+15,994
| +51% | +$223K | ﹤0.01% | 1262 |
|
|
2023
Q3 | $412K | Hold |
31,062
| – | – | ﹤0.01% | 1300 |
|
|
2023
Q2 | $582K | Hold |
31,062
| – | – | ﹤0.01% | 1236 |
|
|
2023
Q1 | $448K | Buy |
31,062
+6,200
| +25% | +$89.4K | ﹤0.01% | 1282 |
|
|
2022
Q4 | $481K | Buy |
24,862
+11,320
| +84% | +$219K | ﹤0.01% | 1292 |
|
|
2022
Q3 | $463K | Buy |
+13,542
| New | +$463K | ﹤0.01% | 1309 |
|